Market Research Reports and Industry Reports

Anti-Diabetic Pharmaceuticals Market in India 2015

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION
Anti-diabetic pharmaceuticals market in India is considered to be one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world, after China, the market is characterized by a huge demand for anti-diabetic drugs. Huge increase in the number of diabetic patients promotes growth of the anti-diabetics pharmaceutical industry. The incidence of diabetes is higher in developed countries because of unhealthy lifestyles . Development of new and innovative drugs is also providing a boost to the market. Comprehensive health insurance coverage fuels the market growth by raising the affordability among patients. Increasing aging population in India increases the prevalence of diabetes, which in turn gives a boost to the drugs market.
However Price regulation in the insulin market and competition from alternative diabetes treatment hinders the growth of Anti-diabetic pharmaceuticals market in India. In spite of substantial demand-supply gap in the insulin market, foreign manufacturers and importers are facing a huge price challenge. Now-a-days People are becoming more aware of diabetes ,and are trying to move away from unhealthy sedentary lifestyles. Increasing awareness on part of the consumers are making them incorporate more physical exercises and avoid junk food. Such consciousness on part of the consumers is decreasing the growth of diabetes, which is limiting the growth of the anti-diabetic pharmaceutical market to some extent. The Indian Government, on its part, has introduced some diabetes control programmes. Various initiatives taken by the government is providing a boost to this market. The market is expected to exhibit steady growth over the next few years.
Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2011-12 2014-15), Inflation Rate: Monthly (Dec 2014-Jan 2015 Mar 2015-Apr 2015)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2014 Jul 2014), Exchange Rate: Monthly (Dec 2014 May 2015)
Slide 4: Lending Rate: Annual (2011-12 2014-15), Trade Balance: Annual (2011-12 2014-15), FDI: Annual (2009-10 2013-14)

Introduction
Slide 5: Types of diabetes
Slide 6: Classification of the diabetes market
Slide 7: Classes of anti-diabetic drugs

Market Overview
Slide 8: Global Anti-Diabetic Pharmaceuticals Market Overview, Size & Growth
Slide 9: Indian Anti-Diabetic Pharmaceuticals Market Overview, Size & Growth
Slide 10: Global Diabetes map

Drivers & Challenges
Slide 11: Summary
Slide 12-15: Key Drivers
Slide 16-17: Key Challenges

Government Initiatives
Slide 18: Government programmes

Market Value Chain
Slide 19: Pharmaceutical Value Chain
Slide 20: Multistage Drug Development Process

Regulation and Patents
Slide 21: Drug regulations
Slide 22-23: Drugs approved for marketing in India
Slide 24: Regulatory Frameworks

Competitive Landscape
Slide 25: Competition Overview
Slide 26: Porters Five Forces Analysis
Slide 27-31: Competitive benchmarking
Slide 32-71: Major Public Player

Strategic Recommendations
Slide 72: Key Strategic Recommendations

Appendix
Slide 73: Appendix
Slide 74: Sources of information

List Of Tables

Regulation and Patents
1. Drugs Approved for Marketing in India

Competitive Landscape
1. Public Trading Comparables (FY 2014) Top 3 Companies
2. Company Profiles (All Companies)
a. Company Information (All Companies)
b. Products and Services (All Companies)
c. Key People (All Companies)
d. Key Financial Performance Indicators (All Companies)
e. Key Ratios (All Companies)
f. Business Highlights (All Companies)

Appendix
1. Appendix
2. Sources of Information

List Of Figures

Macroeconomic Indicators
1. GDP at Factor Cost: Quarterly (2011-12 2014-15)
2. Inflation Rate: Monthly (Dec 2014-Jan 2015 Mar 2015-Apr 2015)
3. Gross Fiscal Deficit: Monthly (Feb 2014 Jul 2014)
4. Exchange Rate: Monthly (Dec 2014 May 2015)
5. Lending Rate: Annual (2011-12, 2012-13, 2013-14, 2014-15)
6. Trade Balance: Annual (2011-12, 2012-13, 2013-14, 2014-15)
7. FDI Annual (2010-11, 2011-12, 2012-13, 2013-14)

Market Overview
1. Global Anti-Diabetic Pharmaceuticals Market Size & Growth (Value wise) (2013-2018e)
2. People Living with Diabetes (2013)
3. Global Anti-Diabetic Pharmaceuticals Market Segmentation (2013, 2015e)
4. Indian Anti-Diabetic Pharmaceuticals Market Size & Growth (Value wise) (2013-2018e)
5. Growth in therapeutic segments (2010)
6. Indian Anti-Diabetic Pharmaceuticals Market Segmentation (2010, 2015e)

Drivers & Challenges
1. Top 10 countries for number of people with diabetes (20-79 years) (2013)
2. Demography - People >60 years in India (2005, 2010, 2015)
Competitive Landscape
1. Competitive Benchmarking Key Ratios of Top 3 Companies Operational Basis (FY 2013)
2. Competitive Benchmarking Key Ratios of Top 3 Companies Financial Basis (FY 2013)
3. Company profiles (All Companies)
a. Financial Snapshot (All companies)
b. Key Business Segments (All Companies)
c. Key Geographic Segments (All Companies except for GlaxoSmithKline Pharmaceuticals Ltd.)

Anti-Diabetic Pharmaceuticals Market in India 2015

Anti-diabetic pharmaceuticals market in India is considered to be one of the most lucrative diabetes markets in the world. Since India is the second largest diabetic pool in the world,

USD 1050View Report

Europe Nuclear Medicine-Radiopharmaceuticals Market Report 2016

Notes:Sales, means the sales volume of Nuclear Medicine-RadiopharmaceuticalsRevenue, means the sales value of Nuclear Medicine-RadiopharmaceuticalsThis report studies sales (consumption) of Nuclear Medicine-Radiopharmaceuticals in Europe market, especially in Germany, UK, France,

USD 3900View Report

United States Nuclear Medicine & Radio Pharmaceuticals Market Report 2016

Notes:Sales, means the sales volume of Nuclear Medicine & Radio PharmaceuticalsRevenue, means the sales value of Nuclear Medicine & Radio PharmaceuticalsThis report studies sales (consumption) of Nuclear Medicine & Radio

USD 3800View Report

Europe Nuclear MedicineRadio Pharmaceuticals Market Report 2016

Notes:Sales, means the sales volume of Nuclear MedicineRadio PharmaceuticalsRevenue, means the sales value of Nuclear MedicineRadio PharmaceuticalsThis report studies sales (consumption) of Nuclear MedicineRadio Pharmaceuticals in Europe market, especially in

USD 3900View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 1050
  • Site Price    $ 1575
  • Enterprise Wide Licence    $ 2100
$ 1050

Reports Details

Published Date : Jul 2015
No. of Pages :74
Country :India
Category :Healthcare
Publisher :Netscribe
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment